Host: Michael Greenberg, MD

Guest: Amy Derick, MD

Dr. Michael Greenberg speaks with Dr. Amy Derick about her involvement with the Women's Dermatologic Society and how the organization is working to support both men and women in the specialty.

Host: Michael Greenberg, MD

Guest: Wendy Roberts, MD

Dr. Michael Greenberg speaks with Dr. Wendy Roberts about her involvement with the Women's Dermatologic Society and how the organization is working to support both men and women in the specialty.

Host: Maurice Pickard, MD

Guest: Michael Brannigan, PhD

Host Dr. Pickard is joined by Michael Brannigan of the Center for Practical Bioethics to talk about ethical issues that arise in coordinating medical responses to national disasters.

Host: Leslie P. Lundt, MD

Guest: Stephen Dewey, PhD

What should every practicing physician know about neuroanatomy? Host Dr. Leslie Lundt asks Senior scientist at BHL, Dr. Stephen Dewey to review what we have learned about neuroscience since finishing medical school.

Host: Leslie P. Lundt, MD

Guest: Stephen Dewey, PhD

GVG, known as vigabatrin in the 70 countries where it is used for treating epilepsy, has a unique mechanism of action. Dr. Stephen Dewey of BHL explains to host Dr. Leslie Lundt his research into this compound and how it potentially could change the course of addictive disorders.

Host: Leslie P. Lundt, MD

Guest: Stephen Dewey, PhD

Senior scientist at Brookhaven National Laboratory, Dr. Stephen Dewey, tells host Dr. Leslie Lundt about his work educating 125,000 children and teens every year about how drugs of abuse affect the brain. Dr. Dewey also shares what he has learned from the students and how it has changed his research.

Host: Leslie P. Lundt, MD

Guest: Stephen Dewey, PhD

Do drug abusers' brains look different because of drug use, or do they use drugs because their brains are different to begin with? Recent advances in brain imaging have revolutionized our understanding of addictive disorders. Join host Dr. Leslie Lundt and Stephen Dewey, PhD as they discuss what we now know about neurochemical and receptor changes due to drug abuse.

Host: Lee Freedman, MD

Guest: Daniel Mazanec, MD

Dr. Mazanec, associate director of the Center for Spine Health at the Cleveland Clinic, discusses the rational and evidenced based approach to treating lumbar radiculopathy. What treatments are of merit and which should be avoided?

Host: Lee Freedman, MD

Guest: Daniel Mazanec, MD

Dr. Mazanec, associate director of the Center for Spine Health at the Cleveland Clinic, discusses older and new data that address, in an evidenced-based manner, the approach to the treatment of lumbar radiculopathy. Is an aggressive, surgical based approach better than a conservative medical approach?

Host: Bruce Japsen

Guest: Dennis O'Leary, MD

He runs an organization designed to stop medical errors at U.S. hospitals in a climate where everyone from consumer groups, patients and members of Congress are complaining about patient safety. Dr. Dennis O'Leary tells Bruce Japsen what doctors, hospitals and other medical professionals need to do improve patient safety.